Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-30 · accession 0001567619-22-000224 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-01-04 | 2021-12-30+ | MEDP | Medpace Investors, LLC | 10% | S - Sale | $217.02 | -50.2K | 5.52M | -0.9% | -$10.89M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-03 | S | D | 19,744 | $212.70 | 5,486,357 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. (F4) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $217.36. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2021-12-31 | S | D | 13,069 | $219.14 | 5,506,101 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $217.48 to $220.44. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| 3 | Common | Common Stock | 2021-12-30 | S | D | 17,376 | $220.34 | 5,519,170 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021. (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $218.835 to $222.14. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |